Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;47(4):1497-1502.
doi: 10.1007/s13402-024-00941-x. Epub 2024 Mar 18.

The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells

Affiliations

The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells

Mingjun Lu et al. Cell Oncol (Dordr). 2024 Aug.

Abstract

Radiotherapy is the first line treatment for small cell lung cancer (SCLC); However, radio-resistance accompanies with the treatment and hampers the prognosis for SCLC patients. The underlying mechanisms remains elusive. Here we discovered that self-inflicted DNA breaks exist in SCLC cells after radiation. Moreover, using nuclease siRNA screening combined with high-content ArrayScan™ cell analyzer, we identified that Ribonuclease ZC3H12A is required for the self-inflicted DNA breaks after radiation and for SCLC cell survival after DNA damage. ZC3H12A expression was increased in response to DNA damage and when ZC3H12A was knocked down, the DNA repair ability of the cells was impaired, as evidenced by decreased expression of the DNA damage repair protein BRCA1, and increased γH2AX at DNA damage sites. Colony formation assay demonstrates that ZC3H12A knocked down sensitized small cell lung cancer radiotherapy. Therefore, the Ribonuclease ZC3H12A regulates endogenous secondary breaks in small cell lung cancer and affects DNA damage repair. ZC3H12A may act as an important radiotherapy target in small cell lung cancer.

Keywords: DNA damage repair; Nuclease; Radiotherapy; Small cell lung cancer; ZC3H12A.

PubMed Disclaimer

Similar articles

References

    1. W.J. Petty, L. Paz-Ares, Emerging strategies for the treatment of small cell lung cancer: a review. JAMA Oncol. 9(3), 419–429 (2023) - DOI - PubMed
    1. Z. Megyesfalvi, et al., Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions. CA Cancer J. Clin. 73(6), 620–652 (2023) - DOI - PubMed
    1. R.-X. Huang, P.-K. Zhou, DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct. Target Ther. 5(1), 60 (2020) - DOI - PubMed - PMC
    1. T.D. Halazonetis, V.G. Gorgoulis, J. Bartek, An oncogene-induced DNA damage model for cancer development. Science (New York, N.Y.) 319(5868), 1352–1355 (2008) - DOI - PubMed
    1. T. Soussi, C. Béroud, Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer 1(3), 233–240 (2001) - DOI - PubMed

LinkOut - more resources